Nugen Medical Devices Inc (NGMD.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 453 | 131 | 193 | 87 | 605 |
| Receivables | 329 | 243 | 212 | 434 | 447 |
| Inventories | 71 | 77 | 15 | 10 | 9 |
| TOTAL | $1,692 | $567 | $641 | $537 | $1,192 |
| Non-Current Assets | |||||
| PPE Net | 133 | 163 | 13 | 13 | 14 |
| Intangibles | 6,073 | 6,120 | 5,803 | 5,979 | 6,294 |
| TOTAL | $6,206 | $6,282 | $5,816 | $5,992 | $6,308 |
| Total Assets | $7,898 | $6,849 | $6,457 | $6,529 | $7,499 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,942 | 83 | 50 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,188 | 1,442 | 780 | 1,157 | 774 |
| TOTAL | $3,317 | $1,730 | $837 | $1,185 | $800 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,729 | 7,163 | 6,370 | 5,679 | 5,597 |
| Deferred Revenues | 37 | 37 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 195 | 175 | 350 | 349 | 347 |
| TOTAL | $5,936 | $7,382 | $6,720 | $6,027 | $5,944 |
| Total Liabilities | $9,254 | $9,112 | $7,557 | $7,212 | $6,743 |
| Shareholders' Equity | |||||
| Common Shares | 16,716 | 15,072 | 15,077 | 14,603 | 14,603 |
| Retained earnings | -22,660 | -20,608 | -19,132 | -18,719 | -17,304 |
| Other shareholders' equity | 4,588 | 3,274 | 2,956 | 3,434 | 3,458 |
| TOTAL | $-1,356 | $-2,262 | $-1,100 | $-682 | $756 |
| Total Liabilities And Equity | $7,898 | $6,849 | $6,457 | $6,529 | $7,499 |